Dark Forest Capital Management
AEON icon

Dark Forest Capital Management’s AEON Biopharma AEON Stock Holding History

Dark Forest Capital Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,051
Closed -$3.65M – 1160
2022
Q4 		$3.65M Buy
5,051
+4,202
+495% +$3.01M 0.9% 28
2022
Q3 		$602K Buy
849
+503
+145% +$356K 0.1% 219
2022
Q2 		$244K Hold
346
– – 0.05% 284
2022
Q1 		$243K Sell
346
-108
-24% -$75.7K 0.06% 344
2021
Q4 		$317K Buy
+454
New +$319K 0.12% 169

Other funds holding AEON

Saba Capital Management
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Fir Tree Capital Management
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
Empyrean Capital Partners
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
Tenor Capital Management
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
Periscope Capital
Periscope Capital Toronto, Ontario, Canada $990M AUM 4.73% 1-Year Est. Return
Sandia Investment Management
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
Shaolin Capital Management
Shaolin Capital Management Miami, Florida $2.42B AUM 0.61% 1-Year Est. Return
Meteora Capital
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

Dark Forest Capital Management's AEON Position: Q1 2023 in Review

Dark Forest Capital Management sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 5,051 shares — an estimated $3.65M sold.

Dark Forest Capital Management first reported a position in AEON in Q4 2021 and held it in 5 quarters. The position peaked at $3.65M in Q4 2022. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.

  • Dark Forest Capital Management reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 5,051 AEON Biopharma shares in Q1 2023, an estimated $3.65M.
  • Dark Forest Capital Management first reported a position in AEON Biopharma in Q4 2021 and held it in 5 quarters.
  • Dark Forest Capital Management's AEON Biopharma position peaked at $3.65M in Q4 2022.
  • 21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.

Based on Dark Forest Capital Management's 13F filing for Q1 2023, filed 12 May 2023.